Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein-Reference-Cited by-同舟云学术

Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein

Published:2011-05 Issue:21 Volume:286 Page:18756-18765
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Aertgeerts Kathleen,Skene Robert,Yano Jason,Sang Bi-Ching,Zou Hua,Snell Gyorgy,Jennings Andy,Iwamoto Keiji,Habuka Noriyuki,Hirokawa Aki,Ishikawa Tomoyasu,Tanaka Toshimasa,Miki Hiroshi,Ohta Yoshikazu,Sogabe Satoshi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference43 articles.

1. Untangling the ErbB signalling network

2. Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors

3. Humanization of an anti-p185HER2 antibody for human cancer therapy.

4. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

5. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy;Journal of Molecular Structure;2024-11

2. Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes;Cancer Treatment Reviews;2024-11

3. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

4. Immunostaining and gene expression of epidermal growth factor receptors (HER1/HER2) in canine cutaneous squamous cell carcinoma;Research in Veterinary Science;2024-09

5. Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies;European Journal of Medicinal Chemistry;2024-09